Adds mucopolysaccharidosis type I and glycogen storage disorder type II to the state's newborn screening panel (EN +$187,717 GF EX See Note)
Provides relative to the mandatory screening of all newborns for early detection of the cytomegalovirus (CMV) (OR NO IMPACT See Note)
Requires all newborns to be screened for adrenoleukodystrophy
Provides relative to newborn screening for certain genetic conditions (EN SEE FISC NOTE GF EX See Note)
Adds mucopolysaccharidosis type I and glycogen storage disorder type II to the state's newborn screening panel
AN ACT relating to newborn and infant screenings.
AN ACT relating to newborn and infant screenings.
Relating to requiring the Health Department to mandate mucopolysaccharidosis type 1 (MPS1) test for newborn babies, to be known as Embie’s Law
Congenital Heart Disease Tests For Infants
An Act Concerning Newborn Screening For Krabbe Disease.